In Vivo Application of Labeled Cells

Deze pagina is nog niet in het Nederlands beschikbaar

Deze pagina is niet in het Nederlands beschikbaar.

Principal Investigator for Radiology: Monique R Bernsen, PhD

Our experience and knowledge regarding cell labeling and cell imaging is used in translational research regarding stem cell therapy in collaboration with other departments in the Erasmus MC. Two main in vivo applications for stem cell therapy are being studied.

 

Stem cell therapy for myocardial infarction

In collaboration with the Department of Cardiology we are implementing cell imaging using high resolution MRI to study clinically relevant principles of cardiac stem cell therapy in small laboratory animals on a clinical scanner. Using the standard clinical imaging gradients, pulse sequences and ECGs, in combination with sensitive small radius surface coils, we are able to image all relevant pulse sequences in rats as well as mice (Figure 3). While visualization of labeled cells in tissue from body parts not affected by uncontrolled motion such as breathing and heartbeat is quite feasible with relevant sensitivity and resolution, the sensitivity is expected to be severely limited in cardiac tissue, due to motion artifacts caused by the beating heart. We are currently able to detect 1000 iron-oxide labeled cells and have also imaged cells labeled with a Gd-based contrast agent, resulting in positive contrast. Further efforts will be focused on increasing the detection sensitivity of labeled cells in the myocardium of living animals and looking at therapeutic potential of various cell types.

  


Figure 3.

 

Stem cell therapy for musculoskeletal disorders

In collaboration with the Department of Orthopedics we are studying the use of cell imaging by high resolution MRI for cell-based therapy in musculoskeletal disorders. We have assessed the feasibility of labeling mesenchymal stem cells and chondrocytes with iron-oxide nanoparticles. We have already established that both cell types can be labeled with iron-oxide particles and are able to retain the iron oxide particles for several weeks in vitro and in vivo. In addition, we have also demonstrated that MSC can be efficiently labeled with iron-oxide particles without compromising their multi-lineage potential (Figure 2 and Piotr figure 7). Further research efforts will be focused on developing imaging protocols for the detection of labeled cells in affected joints and assessment of therapeutic potential by in vivo imaging.

 

 

Funding: Erasmus MC Translational Research Seed Grant 2004-2006: "MRI tracking of transferred cells in vivo".

 

Participating researchers Dept. of Radiology: Sandra van Tiel , Linda van der Graaf, Robert-Jan van Geuns, Gavin Houston, Gabriel Krestin, Piotr Wielopolski.

  

Collaborations:

Country

City (State)

Institute

Department

Collaborator

Germany

Munich

GE Medical Systems [ASL Europe]

Timo Schirmer, PhD

the Netherlands

‘s Hertogenbosch

GE Medical Systems [ASL Europe]

Gavin C Houston, PhD

the Netherlands

Delft

Flick Engineering Solutions

Herman Flick, MEng

the Netherlands

Delft

University of Technology

Reactor Instituut

Gerben A Koning, PhD

the Netherlands

Eindhoven

Technical University

Biomedical Engineering

Klaas Nicolay, PhD

the Netherlands

Eindhoven

Technical University

Biomedical Engineering

Gustav J. Strijkers, PhD

the Netherlands

Enschede

University of Twente

Biomedical Optics

Kiran Kumar Thumma

the Netherlands

Rotterdam

Erasmus MC

Cardiology

Heleen MM van Beusekom, PhD

the Netherlands

Rotterdam

Erasmus MC

Cardiology

Ewout Jan van den Bos, MD, PhD

the Netherlands

Rotterdam

Erasmus MC

Cardiology

Dirk J Duncker, MD, PhD

the Netherlands

Rotterdam

Erasmus MC

Cardiology

Wim J van der Giessen, MD, PhD

the Netherlands

Rotterdam

Erasmus MC

Hepatogastroenterology

Ernst J Kuipers, MD, PhD

the Netherlands

Rotterdam

Erasmus MC

Neonatology

Ingrid B Renes, PhD

the Netherlands

Rotterdam

Erasmus MC

Nuclear Medicine

Marion de Jong, PhD

the Netherlands

Rotterdam

Erasmus MC

Orthopedics

Eric J Farrell, PhD

the Netherlands

Rotterdam

Erasmus MC

Orthopedics

Gerjo JVM van Osch, PhD

the Netherlands

Rotterdam

Erasmus MC

Orthopedics

Harrie H Weinans, PhD

the Netherlands

Rotterdam

Erasmus MC

Plastic & Reconstructive Surgery

Ronald I Siphanto, MD

the Netherlands

Rotterdam

Erasmus MC

Surgical Oncology

AMM (Lex) Eggermont, MD, PhD

the Netherlands

Rotterdam

Erasmus MC

Surgical Oncology

Timo LM ten Hagen, PhD

the Netherlands

Rotterdam

Erasmus MC

Surgical Oncology

Gerben A Koning, PhD

the Netherlands

Rotterdam

Erasmus MC

Virology

Fiona Read

the Netherlands

Rotterdam

Erasmus MC

Virology

Thijs Kuiken, DVM, PhD, DACVP

USA

Milwaukee (WI)

GE Medical Systems [ASL Central]

Jason A Polzin, PhD

USA

San Francisco (CA)

University of California

Radiology

Robert C Brasch, MD